Peng, L., Chen, Y., Chen, T., Wang, J., Hu, X., Li, Y., Zhu, J., Fang, X., Liu, J. (2026). CAREFOL: A phase 3, randomized, open-label, multicenter trial of camrelizumab and rivoceranib with or without intravenous FOLFOX chemotherapy as first-line treatment for unresectable hepatocellular carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps4257